Integrating multi-omics data with artificial intelligence to decipher the role of tumor-infiltrating lymphocytes in tumor immunotherapy
- PMID: 40435910
- DOI: 10.1016/j.prp.2025.156035
Integrating multi-omics data with artificial intelligence to decipher the role of tumor-infiltrating lymphocytes in tumor immunotherapy
Abstract
Tumor-infiltrating lymphocytes (TILs) are capable of recognizing tumor antigens, impacting tumor prognosis, predicting the efficacy of neoadjuvant therapies, contributing to the development of new cell-based immunotherapies, studying the tumor immune microenvironment, and identifying novel biomarkers. Traditional methods for evaluating TILs primarily rely on histopathological examination using standard hematoxylin and eosin staining or immunohistochemical staining, with manual cell counting under a microscope. These methods are time-consuming and subject to significant observer variability and error. Recently, artificial intelligence (AI) has rapidly advanced in the field of medical imaging, particularly with deep learning algorithms based on convolutional neural networks. AI has shown promise as a powerful tool for the quantitative evaluation of tumor biomarkers. The advent of AI offers new opportunities for the automated and standardized assessment of TILs. This review provides an overview of the advancements in the application of AI for assessing TILs from multiple perspectives. It specifically focuses on AI-driven approaches for identifying TILs in tumor tissue images, automating TILs quantification, recognizing TILs subpopulations, and analyzing the spatial distribution patterns of TILs. The review aims to elucidate the prognostic value of TILs in various cancers, as well as their predictive capacity for responses to immunotherapy and neoadjuvant therapy. Furthermore, the review explores the integration of AI with other emerging technologies, such as single-cell sequencing, multiplex immunofluorescence, spatial transcriptomics, and multimodal approaches, to enhance the comprehensive study of TILs and further elucidate their clinical utility in tumor treatment and prognosis.
Keywords: Artificial intelligence; Deep learning; Digital pathology; Machine learning; Tumor microenvironment; Tumor-infiltrating lymphocytes.
Copyright © 2025 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis.Front Immunol. 2025 Jan 6;15:1511866. doi: 10.3389/fimmu.2024.1511866. eCollection 2024. Front Immunol. 2025. PMID: 39835135 Free PMC article.
-
Tumor infiltrating lymphocytes (TILs) - Pathologia, quo vadis? - A global survey.Pathol Res Pract. 2025 Feb;266:155775. doi: 10.1016/j.prp.2024.155775. Epub 2024 Dec 13. Pathol Res Pract. 2025. PMID: 39700663 Review.
-
Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy.Crit Rev Oncol Hematol. 2024 Oct;202:104471. doi: 10.1016/j.critrevonc.2024.104471. Epub 2024 Aug 8. Crit Rev Oncol Hematol. 2024. PMID: 39117163 Review.
-
Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review.BMC Cancer. 2024 Sep 30;24(1):1202. doi: 10.1186/s12885-024-12962-8. BMC Cancer. 2024. PMID: 39350098 Free PMC article.
-
Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma.Expert Rev Mol Diagn. 2024 Apr;24(4):299-310. doi: 10.1080/14737159.2024.2312102. Epub 2024 Feb 5. Expert Rev Mol Diagn. 2024. PMID: 38314660 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical